This new report provides analysis of Virbac’s capabilities, goals and strategies in the global animal health market, including:

- Sales and growth
- Eli Lilly dog parasiticides acquisition
- Product portfolio
- Formulation know-how
- Waltham nutrition products
- Reorganized European distribution
- Decentralized approach for food-producing animals
- Benefitting from new companion animal products
- Focusing on niche markets
- Seeking expansion in the U.S.

The report also provides assessment of major U.S. and international trends with potentially significant impact on the animal health industry during the next five years, including discussion of such issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and includes five-year forecasts for:

- Major market segments
- Key geographic regions